Design of New Drugs for the Treatment of Alzheimer's Disease Based on Tacrine Structure

E-ISSN： 1873-5592|14|3|378-397

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.3, 2013-01, pp. : 378-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 239-255

Bentham Science Publishers

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Controlled Release Tacrine Delivery System for the Treatment of Alzheimer's Disease

By Yang Qing Williams Douglas Owusu-Ababio Godfried Ebube Nkere K. Habib Muhammad J.

Drug Delivery, Vol. 8, Iss. 2, 2001-04 ,pp. : 93-98

Informa Healthcare

Access to resources Recommend Favorite

Beyond Tacrine: Recently Developed Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease

By Unni L.K.

CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 447-460

Adis International

Access to resources Recommend Favorite

Multifunctional Tacrine Derivatives in Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1771-1786

Bentham Science Publishers

Access to resources Recommend Favorite